Pharmaceuticals | Free Full-Text | Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants
Pathogens | Free Full-Text | Predominance of the SARS-CoV-2 Lineage P.1 and Its Sublineage P.1.2 in Patients from the Metropolitan Region of Porto Alegre, Southern Brazil in March 2021
Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Viruses | Free Full-Text | Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy
COVID | Free Full-Text | The Analyses of High Infectivity Mechanism of SARS-CoV-2 and Its Variants
Biomolecules | Free Full-Text | Looking at COVID-19 from a Systems Biology Perspective
Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
Singular Interface Dynamics of the SARS-CoV-2 Delta Variant Explained with Contact Perturbation Analysis | Journal of Chemical Information and Modeling
Multiplex Biosensing for Simultaneous Detection of Mutations in SARS-CoV-2 | ACS Omega
Pharmaceuticals | Free Full-Text | Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
Identifying and extracting bark key features of 42 tree species using convolutional neural networks and class activation mapping | Scientific Reports
Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia - Chan - 2021 - Annals of the New York Academy of Sciences - Wiley Online Library
![Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC) [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13562/1/fig-3-full.png "Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC) [PeerJ]")
Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC) [PeerJ]
Capela e Hospício de S. Crispim e S, Crispiniano - demolid… | Flickr
Microorganisms | Free Full-Text | COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Water | Free Full-Text | Genome Sequencing of SARS-CoV-2 Allows Monitoring of Variants of Concern through Wastewater
Diagnostics | Free Full-Text | Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs
The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape | medRxiv
Molecules | Free Full-Text | Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology
Vaccines | Free Full-Text | COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran
Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo | Journal of Virology
Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers
